Evidence map›Paper›PMID 27613901›Full record

Trial reportNicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco2017

A Randomized Trial of Adjunct mHealth Abstinence Reinforcement With Transdermal Nicotine and Counseling for Smoking Cessation.

Sheila M Alessi, Carla J Rash, Nancy M Petry

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 5 pooled it
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 5 syntheses or guidelines pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. A Scoping Review and Meta-analysis of the Use of Remote Biochemical Verification Methods of Smoking Status in Tobacco Research.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2023
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Competitions for smoking cessation.The Cochrane database of systematic reviews · 2019
    Pooled it
  6. Trial
  7. Trial
  8. Trial
  9. Article
  10. Article
  11. Pilot trial of QuitBet: A digital social game that pays you to stop smoking.Experimental and clinical psychopharmacology · 2022
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Contingency management treatment for substance use disorders: How far has it come, and where does it need to go?Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors · 2017
    Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Sheila M AlessiSchool of Medicine and Calhoun Cardiology Center - Behavioral Health, University of Connecticut, Farmington, CT.
Carla J RashSchool of Medicine and Calhoun Cardiology Center - Behavioral Health, University of Connecticut, Farmington, CT.
Nancy M PetrySchool of Medicine and Calhoun Cardiology Center - Behavioral Health, University of Connecticut, Farmington, CT.
UConn Health · US

Funding

TSF to enhance treatment of cocaine dependenceP50DA009241 · NIDA · YALE UNIVERSITY · PI CARROLL, KATHLEEN M. · 1994 to 2018
$40.5M
Vulnerabilities for coping-related drinking among post-college young adultsP60AA003510 · NIAAA · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI BAUER, LANCE O. · 2008 to 2017
$17.5M
VOUCHERS VS PRIZES--CONTINGENCY MANAGEMENTR01DA013444 · NIDA · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI ALESSI, SHEILA MARIE · 2000 to 2015
$6.2M
Interventions for Unemployed Hazardous DrinkersR01AA023502 · NIAAA · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI ALESSI, SHEILA MARIE, RASH, CARLA J · 2015 to 2019
$3.1M
Contingency Management for Alcohol Use DisordersR01AA021446 · NIAAA · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI ALESSI, SHEILA MARIE · 2013 to 2016
$2.6M
IVR Technology to Mobilize Contingency Management for Smoking CessationR21DA029215 · NIDA · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI ALESSI, SHEILA MARIE · 2011 to 2012
$416k
Contingency Management for Smoking Cessation in the HomelessR21DA031897 · NIDA · UNIVERSITY OF CONNECTICUT SCH OF MED/DNT · PI RASH, CARLA J · 2012 to 2013
$392k
NIAAA NIH HHS P60 AA003510NIAAA NIH HHS R01 AA021446NIAAA NIH HHS R01 AA023502NIDA NIH HHS P50 DA009241NIDA NIH HHS R01 DA013444NIDA NIH HHS R21 DA029215NIDA NIH HHS R21 DA031897
6 · The paper itself

Abstract

introductionAbstinence reinforcement is efficacious for improving smoking treatment outcomes, but practical constraints related to the need for multiple in-person carbon monoxide (CO) breath tests daily to verify smoking abstinence have limited its use. This study tested an mHealth procedure to remotely monitor and reinforce smoking abstinence in individuals' natural environment.

methodsEligible treatment-seeking smokers (N = 90) were randomized to (1) usual care and ecological monitoring with abstinence reinforcement (mHealth reinforcement) or (2) without reinforcement (mHealth monitoring). Usual care was 8 weeks of transdermal nicotine and twice-weekly telephone counseling. Following training, an interactive voice response system prompted participants to conduct CO tests 1-3 daily at pseudorandom times (7 am to 10 pm) for 4 weeks. When prompted, participants used a study cell phone and CO monitor to complete a CO self-test, video record the process, and submit videos using multimedia messaging. mHealth reinforcement participants could earn prizes for smoking-negative on-time CO tests. The interactive voice response generated preliminary earnings immediately. Earnings were finalized by comparing video records against participants' self-reports.

resultsmHealth reinforcement was associated with a greater proportion of smoking-negative CO tests, longest duration of prolonged abstinence, and point-prevalence abstinence during the monitoring/reinforcement phase compared to mHealth monitoring (p < .01, d = 0.8-1.3). Follow-up (weeks 4-24) analyses indicated main effects of reinforcement on point-prevalence abstinence and proportion of days smoked (p ≤ .05); values were comparable by week 24.

conclusionsmHealth reinforcement has short-term efficacy. Research on methods to enhance and sustain benefits is needed. IMPLICATIONS: This study suggests that mHealth abstinence reinforcement is efficacious and may present temporal and spatial opportunities to research, engage, and support smokers trying to quit that do not exist with conventional (not technology-based) reinforcement interventions.

Indexed as

Tobacco Use Cessation DevicesCarbon MonoxideCounselingHumansSmoking CessationTelemedicineCarbon Monoxide

Identifiers

PMID27613901
PMCPMC6075519
OpenAlexW2438588288

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.